Reliability and reproducibility of the Edmondson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens

Archives of Pathology and Laboratory Medicine

Volumn 134, Issue 12, 2010, Pages 1818-1822

  Pirisi, Mario ^a   Leutner, Monica ^b   Pinato, David J ^a   Avellini, Claudio ^c   Carsana, Luca ^b,d   Toniutto, Pierluigi ^c   Fabris, Carlo ^c   Boldorini, Renzo ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d Department of Pathology   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BIOPSY; CANCER STAGING; CLASSIFICATION; EVALUATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY;

AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS;

EID: 78650509026     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chapel F, Guettier C, Chastang C, et al. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes: Group d'Etude et de Traitement du Carcinoma Hepatocellulaire. Cancer. 1996;77(5):864-871.
2. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer. 1954;7(3):462-503.
3. De Carlis L, Giacomoni A, Lauterio A, et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int. 2003;16(2):115-122.
4. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg. 2004;239(2):150-159.
5. Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma: what is the risk and the outcome?: seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33(5):437-447.
6. Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007;245(3):435-442.
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
8. Tamura S, Kato T, Berho M, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;136(1):25-30, discussion 31.
9. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33(5):1080-1086.
10. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228(4):479-490.
11. Senes G, Fanni D, Cois A, Uccheddu A, Faa G. Intratumoral sampling variability in hepatocellular carcinoma: a case report. World J Gastroenterol. 2007;13(29):4019-4021.
12. Mikami Y, Manabe T, Epstein JI, et al. Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement. Hum Pathol. 2003;34(7):658-665.
13. Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol. 2001;35(2):254-258.
14. Prescott RJ, Wells S, Bisset DL, Banerjee SS, Harris M. Audit of tumour histopathology reviewed by a regional oncology centre. J Clin Pathol. 1995;48(3):245-249.
15. Oyama T, Allsbrook WC Jr, Kurokawa K, et al. A comparison of interobserver reproducibility of Gleason grading of prostatic carcinoma in Japan and the United States. Arch Pathol Lab Med. 2005;129(8):1004-1010.
16. Lee JS, Thorgeirsson SS. Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis. 2005;25(2):125-132.
17. Vira MA, Guzzo T, Heitjan DF, et al. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? BJU Int. 2008;101(10):1232-1236.
18. Manion E, Cohen MB, Weydert J. Mandatory second opinion in surgical pathology referral material: clinical consequences of major disagreements. Am J Surg Pathol. 2008;32(5):732-737.
19. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6(7):655-663.
20. Simpson JF, Gray R, Dressler LG, et al. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. J Clin Oncol. 2000;18(10):2059-2069.
21. Stigliano R, Burroughs AK. Should we biopsy each liver mass suspicious for HCC before liver transplantation?-no, please don't. J Hepatol. 2005;43(4):563-568.
22. Smith EH. The hazards of fine-needle aspiration biopsy. Ultrasound Med Biol. 1984;10(5):629-634.